287 results
Page 10 of 15
424B5
61ufv lbff17ft
18 Sep 19
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
uw9u8w uw
10 Sep 19
Regulation FD Disclosure
8:00am
8-K
EX-99.1
uawhgk4hf7 93rsi
5 Sep 19
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference
4:30pm
8-K
EX-99.1
735mdl whws
12 Aug 19
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
6bc14fxtigttaq5
5 Aug 19
VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference
11:04am
8-K
EX-99.1
xlzcgrk
29 Jul 19
VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Part B of Ongoing Phase 1/2a Study of VBI-1901
9:32am
8-K
EX-99.2
a12iy7j7w7l 77ih55
17 Jun 19
Regulation FD Disclosure
7:59am
8-K
EX-99.3
x7ts0k
17 Jun 19
Regulation FD Disclosure
7:59am
8-K
EX-99.1
91we09t9isxtniyu0p
4 Jun 19
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019
2:25pm
8-K
EX-99.1
z3mafz1cy9qe
1 May 19
VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update
12:33pm
8-K
EX-99.1
n3izq
24 Apr 19
VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call
2:25pm
8-K
EX-99.1
tz7gj40gpr5097
17 Apr 19
VBI Vaccines Appoints Dr. Vlad Popovic as Vice President of Clinical Development and Medical Affairs
12:13pm
8-K
EX-99.1
sb3u924o9zb115w13d
12 Apr 19
VBI Vaccines Appoints Joanne Cordeiro to Board of Directors
1:44pm
8-K
EX-99.1
bp1zkdb1s ha9
9 Apr 19
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
3:16pm
8-K
EX-99.1
kycnlah9 k858jg
3 Apr 19
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV
4:30pm
8-K
EX-99.1
yzymyh hk
19 Mar 19
VBI Vaccines to Present at the Oppenheimer 29th Annual Healthcare Conference
1:16pm
8-K
EX-99.1
js5uuso
25 Feb 19
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
5:25pm